Clinical Trials Browser

OTHER × Neoplasm Metastasis × trastuzumab deruxtecan × Clear all

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT06058988 2026-02-23

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

Phase 2 Recruiting

30 enrolled

CNS

Brain Neoplasms, Glioblastoma, Neoplasm Metastasis, Meningeal Carcinomatosis

NCT07126561 2026-01-08

Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers

Phase 2 Not yet recruiting

43 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06663787 2025-11-28

HER2 CR

Active not recruiting

50 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

NCT06504719 2025-09-15

Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan

Completed

312 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

NCT07086768 2025-09-04

Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Not yet recruiting

57 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07151586 2025-09-03

ALTER

Phase 2 Not yet recruiting

260 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT04420598 2025-06-24

DEBBRAH

Phase 2 Completed

41 enrolled 32 charts